An Open Clinical Trial on the Efficacy of Loratadine for the Management of Allergic Pruritus in 27 Cats

Abstract

Cetirizine hydrochloride was administered orally at 5 mg/cat, q24h, to 32 cats with allergic skin disease. Pruritus was reduced in 41% (13/32) of the cats. The antipruritic effect was repeatable and sustainable. There was no significant association between patient age, disease severity, or cutaneous reaction pattern and improvement during cetirizine administration. No adverse side effects were reported.